The cell therapy market has been witnessing remarkable growth, reflecting a paradigm shift in medical science. Valued at USD 16.30 billion in 2023, the market is set to grow at a robust CAGR of 18.1%, reaching USD 72.84 billion by 2032. This rapid expansion is fuelled by an increasing global burden of chronic diseases, significant investments in cell therapy research, and rising clinical trial...